{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:42:03Z","timestamp":1787452923250,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bioorg.2021.104647","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:58:28Z","timestamp":1611017908000},"page":"104647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Discovery of a novel series of indolylchalcone-benzenesulfonamide hybrids acting as selective carbonic anhydrase II inhibitors"],"prefix":"10.1016","volume":"108","author":[{"given":"Priti","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvatha","family":"Purnachander Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baijayantimala","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavitra S.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Arifuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.104647_b0005","doi-asserted-by":"crossref","unstructured":"C. T. Supuran, Carbonic anhydrases: novel therapeutic applications for inhibitors and activators, Nat. Rev. Drug Discov. 7 (2008) 161-181. b) C.B. Mishra, M. Tiwari, C.T. Supuran Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today? Med. Re.s Rev. 40 (2020) 2485-2565.","DOI":"10.1002\/med.21713"},{"key":"10.1016\/j.bioorg.2021.104647_b0010","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/acs.jmedchem.5b01771","article-title":"4-Arylbenzenesulfonamides as human carbonic anhydrase inhibitors (hCAIs): synthesis by Pd nanocatalyst-mediated Suzuki-Miyaura reaction enzyme inhibition and X-ray crystallographic studies","volume":"59","author":"Cornelio","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_b0015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17460441.2013.795145","article-title":"Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors","volume":"8","author":"Simone","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2021.104647_b0020","doi-asserted-by":"crossref","unstructured":"C. T. Supuran, A. Scozzafava, A. Casini, Carbonic Anhydrase Inhibitors, Med. Res. Rev. 23 (2003), 146\u2013189. B) A. Weber, A. Casini, A. Heine, D. Kuhn, C. T. Supuran, A. Scozzafava and G. Klebe, Unexpected Nanomolar Inhibition of Carbonic Anhydrase by COX-2-Selective Celecoxib: New Pharmacological Opportunities Due to Related Binding Site Recognition, J. Med. Chem. 47 (2004) 550-557.","DOI":"10.1021\/jm030912m"},{"key":"10.1016\/j.bioorg.2021.104647_b0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jhet.349","article-title":"Pathak Biological Importance of the Indole Nucleus in Recent Years","volume":"47","author":"Sharma","year":"2010","journal-title":"A Comprehensive Review, J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2021.104647_b0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/13543784.12.2.283","article-title":"Indisulam: an anticancer sulfonamide in clinical trial","volume":"12","author":"Supuran","year":"2003","journal-title":"Expert Opin. Investig. Drugs."},{"key":"10.1016\/j.bioorg.2021.104647_b0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.bjc.6603606","article-title":"A phase I and pharmacokinetic study of indisulam in combination with carboplatin","volume":"96","author":"Dittrich","year":"2007","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.bioorg.2021.104647_b0040","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14756366.2018.1446432","article-title":"Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails","volume":"33","author":"Awadallah","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0045","doi-asserted-by":"crossref","first-page":"9113","DOI":"10.1016\/j.bmc.2008.09.032","article-title":"Carbonic anhydrase inhibitors: Synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3- substituted-phenyl-1H-indole-5-sulfonamides","volume":"16","author":"Guzel","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0050","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3390\/ijms20092354","article-title":"Indole-Based Hydrazones Containing A Sulfonamide Moiety as Selective Inhibitors of Tumor-Associated Human Carbonic Anhydrase Isoforms IX and XII","volume":"20","author":"Demir-Yaz\u0131c\u0131","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2021.104647_b0050","article-title":"Synthesis and In Vitro Inhibition Effect of New Pyrido[2,3-d]pyrimidine Derivatives on Erythrocyte Carbonic Anhydrase I and II","volume":"4","author":"Kuday","year":"2014","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bioorg.2021.104647_h0060","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/14756366.2017.1380638","article-title":"Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms l, ll, lX, and Xll inhibitors","volume":"32","author":"Sri Ramya","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0065","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1016\/j.bmcl.2016.11.017","article-title":"Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides","volume":"26","author":"Arslana","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bioorg.2021.104647_b0060","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/14756366.2018.1428572","article-title":"Carbon- versus sulphur-based zinc binding groupsfor carbonic anhydrase inhibitors","volume":"33","author":"Supuran","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2018.10.068","article-title":"Enhancement of tail hydrophobic interactions within the carbonic anhydrase lX active site via extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumour agents","volume":"162","author":"Eldehna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0080","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1021\/acs.jmedchem.8b00770","article-title":"Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Over-expressing Carbonic Anhydrase IX","volume":"61","author":"Bozdag","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_b0070","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_b0075","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert. Opin. Drug. Discov."},{"key":"10.1016\/j.bioorg.2021.104647_b0080","first-page":"4421","article-title":"Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Expert. Opin. Drug. Discov."},{"key":"10.1016\/j.bioorg.2021.104647_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103839","article-title":"Arifuddin) Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole- 1,2,3-triazole chalcone hybrids","volume":"99","author":"Singh","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_b0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0223-5234(99)80057-9","article-title":"Anti-inflammatory, analgesic and antipyretic 4,6-disubstituted 3-cyano-2-aminopyridines","volume":"34","author":"Manna","year":"1999","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_b0095","doi-asserted-by":"crossref","unstructured":"Abdul-Malek S. Altamimi, Ahmed M. Alafeefy, A. Balode, I. Vozny, A. Pustenko, Mohey Eldin El Shikh, F. A. S. Alasmary, Sherif A. Abdel-Gawad & R. \u017dalubovskis. Symmetric molecules with 1,4-triazole moieties as potent inhibitors of tumour-associated lactate dehydrogenase-A, J. Enzyme Inhib. Med. Chem. 33 (2018) 147-150.","DOI":"10.1080\/14756366.2017.1404593"},{"key":"10.1016\/j.bioorg.2021.104647_b0100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2016.05.038","article-title":"Hit to lead optimization of a series ofN-[4-(1,3-benzothiazol-2-yl)phenyl]acetamides as monoacylglycerol lipase inhibitors withpotential anticancer activity","volume":"121","author":"Afzal","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_b0105","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0125","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1021\/jm501314c","article-title":"Structural Insights on Carbonic Anhydrase Inhibitory Action, Isoform Selectivity and Potency of Sulfonamides and Coumarins Incorporating Arylsulfonylureido Groups","volume":"57","author":"Bozdag","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0130","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","article-title":"Substituted Sulfocoumarins Are Selective Carbonic Anhdydrase IX and XII Inhibitors with Significant Cytotoxicity against Colorectal Cancer Cells","volume":"58","author":"Grandane","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/14756366.2013.879656","article-title":"Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors","volume":"30","author":"Korkmaz","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0140","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/14756366.2014.892936","article-title":"Computational investigation of the selectivity of salen and tetrahydro salen compounds towards the tumor-associated hCA XII isozyme","volume":"30","author":"Akdemir","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0145","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1021\/jm050483n","article-title":"Carbonic Anhydrase Inhibitors. The Mitochondrial Isozyme VB as a New Target for Sulfonamide and Sulfamate Inhibitors","volume":"48","author":"Nishimori","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/14756366.2014.928704","article-title":"Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoyl carbamates","volume":"30","author":"Gocer","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/14756366.2014.942659","article-title":"New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII","volume":"30","author":"Ceruso","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/14756366.2014.944178","article-title":"Drosophila melanogaster: a model organism for controlling Dipteran vectors and pests","volume":"30","author":"Emameh","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0165","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3109\/14756366.2014.957202","article-title":"Inhibition studies of quinazoline-sulfonamide derivatives against the g-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis","volume":"30","author":"Alafeefy","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_b0125","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0223-5234(96)89555-9","article-title":"Carbonic anhydrase activators. Part 14. Syntheses of mono and bis pyridinium salt derivatives of 2-amino-5 (2-aminoethyl)- and 2-amino-5-(3-aminopropyl)-1,3,4-thiadiazole and their interaction with isozyme II","volume":"31","author":"Supuran","year":"1996","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.104647_h0175","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1016\/j.bmcl.2005.04.055","article-title":"Carbonic anhydrase inhibitors-Inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff\u2019s bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes","volume":"15","author":"Puccetti","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2021.104647_h0180","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0223-5234(96)85163-4","article-title":"Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes","volume":"31","author":"Supuran","year":"1996","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:12:41Z","timestamp":1758615161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":36,"alternative-id":["S0045206821000237"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104647","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a novel series of indolylchalcone-benzenesulfonamide hybrids acting as selective carbonic anhydrase II inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.104647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104647"}}